Introduction {#sec1}
============

The heme-containing cytochrome P450 monooxygenases (CYPs) demonstrate broad substrate tolerance as they are vital for the metabolization of xenobiotics and drug molecules,^[@ref1]^ as well as for the biosynthesis of hormones.^[@ref2]^ Due to this substrate promiscuity and their regio- and stereospecificity, they have become the topic of extensive research. CYP enzymes catalyze aliphatic and aromatic C--H oxidations,^[@ref3]^ epoxidations of olefins, sulfoxidations, dehalogenations, *N*- and *O*-dealkylations, desaturations, and oxidative decarboxylations.^[@ref4]^ More recently, "non-natural" applications of CYPs have been enabled through bioengineering their structure and function.^[@ref5]^ Specifically, they have been utilized for the introduction of nitrogen, boron, or silicon into organic frameworks^[@ref6]^ or carbene- and nitrene-mediated reactions.^[@ref7]^

The vast majority of CYP monooxygenases require one molecule of O~2~, two protons, and two electrons, which are transferred one at a time from an external redox partner throughout the catalytic cycle.^[@ref1],[@ref8]^ A common issue of CYP monooxygenases is the uncoupling reactions, leading to the loss of redox equivalents in the form of hydrogen peroxide or superoxide anions which in turn harm the enzyme. A handful of CYPs have evolved the ability to utilize hydrogen peroxide as both electron- and oxygen-source instead, by reversing the peroxide shunt that leads to uncoupling.^[@ref9]^ These CYP-"peroxygenases" belong to the CYP152 subfamily, do not require a redox partner, and are able to hydroxylate carboxylic acids. A well-studied peroxygenase from the CYP152 family is the CYP OleT~JE~ (CYP152L1) from *Jeotgalicoccus sp*. ATCC 8456.^[@ref10]^ This enzyme catalyzes the oxidative decarboxylation of long-chain fatty acids yielding terminal olefins alongside α- and β-hydroxylation ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a).^[@ref11]^ With hydrogen peroxide, the enzyme works as peroxygenase; however, it was also shown to efficiently work as monooxygenase.^[@cit10c]^ Recent results demonstrated that, in this case, OleT~JE~ utilizes electrons derived from a redox system which are then lost by uncoupling and re-enter the catalytic cycle as hydrogen peroxide. Therefore, Compound I can only be formed with hydrogen peroxide, and the enzyme predominantly acts as peroxygenase.^[@cit9e]^ Since selective oxidative decarboxylation opens access to bioderived olefins from carboxylic acids, understanding the mechanism and product formation of these enzymes is an important basis for the development of more efficient and selective enzyme variants.

![(a) Substrates **1a**--**5a** and Products Obtained by CYP152-Transformation of Fatty Acids and b) Potential Products and Their Stereoisomers: **1b**--**5b** from Oxidative Decarboxylation, **1c**--**5c** from α--Hydroxylation, and **1d**--**5d** from β-Hydroxylation](cs-2018-03733n_0007){#sch1}

Most studies on the reaction profile of CYP152 enzymes in general, but OleT~JE~ especially, focused on identifying main product distributions rather than a careful calibration with authentic references and quantification of all products.^[@cit9g],[@cit10a],[@cit10c],[@ref12]^ On top of that, information regarding stereochemical preferences of OleT~JE~ catalysis remains scarce.^[@ref13]^ Overall, the enzyme's broad reactivity produces not only enantiomeric α- or β-hydroxy acids, but also regioisomeric alkenes. For instance, in the reaction of *rac*-**2a**, 13 different compounds must be considered ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b).

Quantum mechanics/molecular mechanics (QM/MM) studies, focused on product distributions in CYP OleT~JE~ for oxidative decarboxylation versus α- and β-hydroxylation, showed^[@ref14]^ and stopped-flow experiments confirmed^[@ref10],[@ref11]^ that all products originate from a rate-determining hydrogen atom abstraction of either Cα or Cβ.

To address major questions related to the structure, function, and substrate scope of CYP152 peroxygenases we decided to perform a combined experimental and computational study into these systems: The primary oxidation-product distribution for a structurally diverse set of carboxylic acids **1a**--**5a** bearing a stereocenter at Cα ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a), using peroxygenases OleT~JE~, CYP~Cla~ from *Clostridium acetobutylicum* (CYP152A2),^[@ref15]^ and CYP~BSβ~ from *Bacillus subtilis* (CYP152A1),^[@ref16]^ was evaluated and revealed an unprecedented α,β-desaturation activity. The origin of the different reactivities was rationalized by computational methods based on an active site complex of CYP OleT~JE~.

Methods {#sec2}
=======

General procedure for Biotransformations with OleT--CamAB--FDH reaction cascade {#sec2.1}
-------------------------------------------------------------------------------

Biotransformations of substrates using OleT~JE~ were performed as previously described.^[@cit10c]^ A typical reaction mixture contained purified OleT~JE~ (6 μM), putidaredoxin CamAB (0.05 U mL^--1^), catalase (500 U mL^--1^), substrate (10 mM), ethanol (5% v/v), potassium phosphate buffer (pH 7.5, 100 mM), nicotinamide adenine dinucleotide (NADH) or NAD^+^ (200 μM), formate dehydrogenase (FDH; 2 U mL^--1^), and ammonium formate (100 mM). All reactions were performed at atmospheric pressure at room temperature (or 4 °C) in a 1 mL volume in a 4 mL glass vial closed with a polytetrafluoroethylene (PTFE) septum with shaking at 170 rpm for 24 h. The activity of the CamAB system and the concentration of active, purified OleT~JE~ were determined prior to each biotransformation using a cytochrome c-based activity assay and CO-titration, respectively ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf)). Biotransformations as well as negative control experiments (without OleT~JE~) were performed in triplicate for each substrate and were stopped by freezing the samples at −20 °C.

Biotransformations with CYP~Cla~ and CYP~BSβ~ {#sec2.2}
---------------------------------------------

Biotransformations using CYP~Cla~ and CYP~BSβ~ were done in 4 mL glass vials sealed with a PTFE septum with shaking at 170 rpm for 24 h at room temperature. The reaction mixture contained purified enzyme (6 μM), substrate (10 mM), and ethanol (5% v/v). H~2~O~2~ was used as the sole oxidant, and supply was provided using a syringe pump (kdScientific). A flow of 1.6 mM H~2~O~2~ h^--1^ (5 μL h^--1^ from a 320 μM stock solution) was set, and 16 mM (50 μL) was added in total. Biotransformations and negative control experiments (without enzyme) were performed in triplicate for each substrate and were stopped by freezing the samples at −20 °C.

Computation {#sec2.3}
-----------

Calculations were performed using previously described and calibrated methods.^[@ref17]^ Density functional theory (DFT) was applied using the unrestricted B3LYP hybrid density functional theory^[@ref18]^ for geometry optimizations and frequencies in the gas phase. The mechanism for the activation of (*R*)- and (*S*)-2-methylbutyric acid (**2a**) by CYP Compound I (CpdI) was studied. The initial calculations used a simplified model (**A**) containing an iron(IV)-oxo porphyrin radical cation model for CpdI, whereby the axial cysteinate residue was abbreviated with thiolate, and all porphyrin substituents were replaced by hydrogen atoms: \[Fe^IV^(O)(Por^+•^)(SH)\]. The general reactivity landscape and electronic structure of intermediates and transition states with the (*S*)-enantiomer of the substrate, leading to either hydroxylation, desaturation, or decarboxylation products, were calculated. In all calculations for model **A**, the geometry optimizations were done with a 6-31G\* basis set^[@ref19]^ on all atoms, except on iron where LANL2DZ with effective core potential (ECP) was used (basis set BS1).^[@ref20]^ To improve the energies a single point with a larger basis set, i.e., 6-311+G\* on all atoms, was performed (basis set BS2). Calculations were run in the Gaussian 09 software package^[@ref21]^ and were done on the lowest-energy doublet and quartet spin states.

In a second set of calculations a comprehensive cluster model was investigated (model **B**), based on a detailed analysis of the protein structure and dynamics. In particular, with molecular dynamics simulations the protein and especially the substrate binding pocket flexibility was investigated. However, these studies (Supporting Information, [Figures S1 and S2](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf)) showed little flexibility in substrate positioning and dynamics. Therefore, we decided to use an expanded cluster model rather than QM/MM for detailed studies on the mechanism of substrate activation. These cluster models have been shown to give an accurate representation of enzyme active site activities and reproduce experimental chemo- and regioselectivity patterns.^[@ref22]^ Thus, the small model was expanded with residues representing the substrate binding pocket ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf)) until structure convergence was achieved using procedures as described by Liao et al. (see also [Figure S10](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf)).^[@ref23]^ The energies and structures of the two models were comparable, and hence the calculations were continued with model **A**. The (*S*)*-* and (*R*)*-*enantiomers of the substrate were docked into the 4L40 protein databank (pdb) file^[@cit11a]^ with the SwissDock web service.^[@ref24]^ The 4L40 pdb file is a substrate bound resting state structure, but we removed the original substrate and tested various alternative stable substrate binding positions. A total of three distinct low-energy (*R*)-isomers and five (*S*)-isomers were selected as the starting points of the calculations. Based on these structures and the results from the MD simulations, a model was created that contained the iron(IV)-oxo porphyrin cation radical with thiolate axial ligand and substrate (as in model **A** above) and the side chains of residues located close to the substrate in the active site (Leu~78~, Phe~79~, Ile~170~, Pro~246~, Ala~249~, Phe~291~, and Val~292~; [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"} and [Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf), Supporting Information). The total model included 163 atoms, and constraints were placed on protein backbone atoms to keep the features of the substrate binding pocket; these atoms are highlighted with an asterisk in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. A trimmed proline residue was protonated to account for the lost backbone carbon bond. The system was overall charge neutral and was calculated in the lowest doublet and quartet spin states.

![Active Site Cluster Model of CYP OleT~JE~ with Substrate Bound\
Atoms highlighted with an asterisk were fixed during the geometry optimization.](cs-2018-03733n_0008){#sch2}

The studies on model **B** use the unrestricted B3LYP-GD3^[@ref18],[@ref25]^ density functional method in combination with the def2-SVP^[@ref26]^ basis set on all atoms (basis set BS3). An enlarged basis set (BS4) that incorporates def2-TZVP on all atoms and an implicit solvent model, i.e., the polarized continuum model with water as dielectric constant, was employed to correct the energies for all results for model **B**. Free energies reported here use entropic and thermal (at 298 K) corrections.

Transition states were located by initially running constraint geometry scans between reactants and intermediates (or in between intermediates and products) and vice versa, whereby one degree of freedom was fixed (the reaction coordinate), while all other degrees of freedom were allowed to relax. The maxima of these geometry scans were subjected to a full transition state search in Gaussian using default settings.

Results and Discussion {#sec3}
======================

Identification of Desaturation Activity of OleT~JE~ {#sec3.1}
---------------------------------------------------

The biotransformation of myristic acid (**1a**), 2-methylbutyric acid (**2a**), and 2-phenylbutyric acid (**3a**) by CYP was studied. Even though OleT~JE~ was recently demonstrated to be a true peroxygenase,^[@cit9e]^ the established OleT~JE~--CamAB--FDH reaction system^[@cit10c],[@ref27]^ proved to be very productive in biotransformations and was applied herein. [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} gives the individual product distributions for the reactions of *rac*-**1a**, *rac*-**2a**, and *rac*-**3a** in OleT~JE~.

![OleT~JE~--CamAB--FDH catalyzed transformation of substrates **1a**--**3a** at room temperature and Sankey representation of the product distribution. The width of the lines corresponds to the relative amount of substrate that was converted (left-hand side) and the relative amount of product that was formed (right-hand side).](cs-2018-03733n_0001){#fig1}

With substrate **1a**, OleT~JE~ yielded a mixture of alkene (**1b**) and 3-hydroxymyristic acid (**1d**) as sole products with an overall conversion of 11% matching previous reports.^[@cit10c]^ However, as the product distribution highly depended on the reaction conditions, alternative redox partners were reported to cause also α-hydroxylation,^[@cit11a],[@ref13],[@ref28]^ which was not observed here. By contrast, CYP OleT~JE~ converted **3a** through decarboxylation to form **3b** and α-hydroxylation to generate **3c**, again, matching previous reports with this substrate.^[@ref13]^ Remarkably, strict (*R*)-hydroxylation of **1a** and **3a** was observed leading to (*R*)-**1c** and (*R*)-**3d** with high ee, while a slight (*S*)-preference prevailed for the α-chiral substrate **3a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

###### Products Obtained from the Conversion of **1a**--**5a** by OleT~JE~, CYP~Cla~, or CYP~BSβ~[a](#t1fn1){ref-type="table-fn"}

                                              ox. decarboxylation   α-hydroxylation   β-hydroxylation   α,β-desaturation                                                                      
  ----------------- -------- ---------------- --------------------- ----------------- ----------------- ------------------ ---------------------------------------------- ----- ------------- --------
  OleT~JE~ (rt)     **1a**   7.77             0.78                  130                                 332                0.32 (\>99*R*)                                 53                   
                    **2a**   2.64 (65*R*)     traces                                  0.99 (68*R*)      165                                                                     1.95 (97/3)   315/10
                    **3a**   6.59 (17*R*)     0.46 (1.6/1)          47/30             1.02 (95*R*)      170                                                                                    
                    **4a**   5.89 (39*R*)                                             1.99 (\>95*R*)    332                                                                     0.49 (98/2)   80/2
                    **5a**   3.40 (96*R*)                                             1.40 (\<10)       233                                                                     3.00          500
  OleT~JE~ (4 °C)   **1a**   7.31             1.16                  193                                 332                0.15 (\>99*R*)                                 25                   
                    **2a**   5.69 (\<10)      traces                                  0.44 (20*R*)      74                                                                      0.83 (96/4)   133/5
                    **3a**   6.22 (\<10)      0.54 (1.7/1)          57/33             1.13 (\>95*R*)    188                                                                                    
                    **4a**   7.03 (11*R*)                                             1.30 (\>95*R*)    217                                                                     0.40 (99/1)   66/1
                    **5a**   4.28 (35*R*)                                             0.94 (\<10)       157                                                                     2.63          438
  CYP~Cla~          **1a**   1.18                                                     4.47 (*rac*)      745                                                                                    
                    **2a**   6.86 (17*R*)                                             1.73 (65*R*)      288                                                                                    
                    **3a**   0.61 (93*R*)                                             8.82 (12*R*)      1470                                                                                   
                    **4a**   7.51 (21*R*)                                             1.37 (\>95*R*)    228                                                                                    
                    **5a**   1.65 (99*R*)                                             5.21 (19*R*)      868                                                                                    
  CYP~Bsβ~          **1a**   0.94             1.56                  260               0.49 (67*R*)      82                 0.96 (\>99*R*)                                 16                   
                    **2a**   3.89 (74*R*)                                             3.66 (60*R*)      610                                                                                    
                    **3a**   2.57 (89*R*)                                             4.92 (74*R*)      820                                                                                    
                    **4a**   3.70 (81*R*)                                             3.66 (\>95*R*)    610                                                                     0.46 (96/4)   74/3
                    **5a**   2.43 (\>99*R*)                                           3.91 (79*R*)      652                0.85 (93*R*)[d](#t1fn4){ref-type="table-fn"}   142   0.13          22

Error-margins can be found in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf). Reactions were performed in triplicate with 10 mM substrate for 24 h at either room temperature (rt) or 4 °C.

Secondary oxidation products (e.g., keto acids) were not measured and contribute to the incomplete recovery.

No terminal products (alkenes or hydroxylation products) were detected.

Chiral center is not formed by hydroxylation but is already present in the substrate; traces = only traces of product were detected in headspace gas chromatography with mass spectroscopy (GC-MS; not quantified).

For the small 2-methylbutyric acid (**2a**) the (*S*)-form was preferred, and α-hydroxylation produced (*R*)-**2c**^[@ref29]^ in moderate enantioselectivity. This fits to the trend that CYP450s tend to activate the weakest C--H bond of a substrate,^[@ref30]^ which in this case is Cα. Interestingly, besides the formation of minor amounts of decarboxylation product (**2b**) and α-hydroxylation, OleT~JE~ also led to desaturation of **2a** leading to (*E*/*Z*)-2,3-dimethylacrylic acid (*E*/*Z*-**2e**), which is the first time that fatty acid desaturation has been observed in CYP152 reactions ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

CYP450 desaturations have been observed in rare cases by enzymes from other CYP classes, such as the desaturation of valproic acid demonstrated by Rettie et al. in 1987, or desaturations of ethyl carbamate, sterols, and alkylbenzenes and the terminal desaturation of lauric acid.^[@ref31]^ Density functional theory studies on the regioselective hydroxylation versus desaturation of valproic acid and ethyl carbamate showed a spin-selective reaction mechanism with dominant hydroxylation on the high-spin surface and a mixture of products on the low-spin state.^[@ref32]^ Desaturation reactivity was also already suggested for the CYP152 family member OleT~JE~. However, a combination of overoxidation to the ketone, followed by enolization during the derivatization step, was likely its origin rather than enzyme catalyzed desaturation.^[@ref28]^ Herein, nonenzymatic pathways, such as spontaneous desaturation, dehydration of a hydroxylated metabolite, as well as enzymatic secondary activities of OleT~JE~ and CYP~Bsβ~ on hydroxylated products (e.g., **2c** or **2d**), were excluded with a series of control experiments ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf)).

Reactivity of OleT~JE~, CYP~Cla~, or CYP~BSβ~ {#sec3.2}
---------------------------------------------

Despite the close structural homology of substrates **2a** and **3a**, no desaturation products could be detected for the latter. To understand the reactivity differences of OleT~JE~ with **2a** and **3a**, the further substrates 2-phenylbutanoic acid (**4a**) and 2-phenylpropanoic acid (**5a**) were included in the study, and the product distributions for all substrates were investigated with OleT~JE~ (at both room temperature and 4 °C) and the additional CYP152 orthologues CYP~Cla~ and CYP~BSβ~. While again the OleT~JE~--CamAB--FDH reaction system was used for the OleT~JE~-transformations, CYP~Cla~ and CYP~BSβ~ studies were performed using H~2~O~2~ as the oxidant. All metabolites were carefully quantified, and stereoselectivities and absolute configurations were measured for the products and the substrate ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

The transformation of all substrates by CYP~Cla~ yielded α-hydroxylation products exclusively, whereas OleT~JE~ and CYP~BSβ~ generated a mixture of products. Oxidative decarboxylation was observed for the reactions of OleT~JE~ with **1a** and **3a** and for CYP~Bsβ~ with **1a**. Moreover, α,β-desaturation was found for OleT~JE~ with **2a**, **4a**, and **5a**, as well as for CYP~Bsβ~ with **4a** and **5b**. As such, OleT~JE~ and CYP~BSβ~ give analogous reactivity patterns and product distributions, but yields and turnovers vary. In the majority of studies on OleT~JE~, only linear fatty acids or diacids were investigated as substrates,^[@ref10],[@ref11],[@ref13],[@ref28],[@ref33]^ which do not react through desaturation, and hence this activity has never been reported before.

The overall substrate conversion as a function of isozyme is divergent. In the case of OleT~JE~, the highest conversion and turnover number (TON) was obtained for substrate **5a** (44%, 733 TON). The reaction temperature had a slight impact on the overall reactivity (e.g., 36% conversion, 595 TON, based on the sum of recovered products). By contrast, with CYP~Cla~ and CYP~BSβ~ the highest conversion was with **3a** instead. It needs to be mentioned that secondary oxidation products (e.g., keto acids) were not measured and contribute to the incomplete recoveries that were found.

With OleT~JE~, an almost 2:1 mixture of desaturation product over α-hydroxy acid was obtained with substrates **2a** and **5a**. Interestingly this ratio is reversed for **4a** (1:4), which may be caused by an altered orientation of the substrate in the active site, forced by the additional methyl group of **4a**, leading to a favored rebound over desaturation. This steric demand may also be the reason for the decreased turnovers for substrate **4a** compared to substrate **5a**.

Interestingly, all substrates that show desaturation only gave byproducts from α-hydroxylation. Thus, for **2a**, **4a**, and **5a** the α-hydroxylated product is a tertiary alcohol, and for **4a** and **5a** a benzylic alcohol. These products originate from the breaking of the weakest C--H bond in the molecule, which yields a stable radical. This implies that, for the α-hydroxylation and desaturation of the substrate, Cα--H abstraction is the common initial step in the mechanism. Interestingly, also CYP~Cla~ activates the α-position of all substrates but solely gives α-hydroxylation as products. Therefore, the desaturase activity by OleT~JE~ and CYP~Bsβ~ might originate from an unfavorable oxygen-rebound step due to differences in substrate binding pockets (*vide infra*). Note that, in none of the cases studied, terminal side-chain hydroxylation, i.e., the formation of *term-***2d** or *term-***4d** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}), occurred.

Enantioselectivity of OleT~JE~, CYP~Cla~, or CYP~BSβ~ {#sec3.3}
-----------------------------------------------------

All tested CYP isozymes exhibit a slight stereochemical preference for the (*R*)-enantiomer of α-chiral substrates **2a**--**5a**. Due to the large number of possible reaction pathways, the enantiomeric ratios (*E*-values) could not be calculated in most cases. As CYP~Cla~ did produce only one product, the system can be described using enantiomeric ratios: low *E*-values (\<10) were calculated for substrates **2a**--**5a**, based on the conversion and the substrates ee values. As the reaction of CYP~BSβ~ with substrate **5a** yields only one product (**5d**), and the substrate stereocenter is not altered throughout the reaction, this is the only other reaction that can be described with an enantiomeric ratio. A value of 30 was obtained. For the other reactions, high substrate conversion paired with high ee values (up to 99%) suggests moderate *E*-values. Substrate **2a**, bearing the smallest substituents and therefore the least possible interactions for chiral recognition, gave the lowest ee values. A high stereoselectivity for the (*R*)-enantiomer (ee values of up to 99%) was obtained from β-hydroxylation of substrates **1a** (by OleT~JE~ and CYP~BSβ~) and **5a** (by CYP~BSβ~), which matches previous observations with CYP~BSβ~.^[@cit16c]^ Similarly, α-hydroxylation of **4a** by all enzymes produced (*R*)-**4c** with stereoselectivities of \>95%. Interestingly, this result contrasts the reported selectivity of the CYP152 family member CYP~SPα~.^[@ref34]^ The slightly less bulky substrates **2a**, **3a**, and **5a** were found to be α-hydroxylated by all CYP isozymes with moderate to good ee values. Especially in the case of α-hydroxylation, the stereogenic center is destroyed throughout the reaction mechanism, and the selectivity of the rebound determines the stereochemical outcome. Interestingly, low ee values, paired with high conversion (e.g., CYP~Cla~ and **3a**), suggest that the rebound can occur from both faces of the planar α-radical intermediate. It is worth mentioning that chiral tertiary alcohol moieties in the α-position of carboxylic acids represent attractive synthons, which are difficult to generate by conventional means.

Isotope Labeling Studies {#sec3.4}
------------------------

Overall, the observed selectivity of substrate activation by the CYP isozymes OleT~JE~, CYP~Cla~, and CYP~BSβ~ is clearly dependent on the shape and size of the substrate and its positioning in the binding pocket. Most likely all reactions are initiated by hydrogen atom abstraction from either Cα or Cβ of the substrate. To determine the location of initial Cα--H abstraction for desaturation, regiospecifically deuterated derivatives \[2-^2^H\]-**2a** and \[3,3-^2^H~2~\]-**2a** of 2-methylbutyric acid (**2a**) were synthesized and used as substrate probes for the OleT~JE~/CamAB-FDH system (see the [SI](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf)).

As expected, the introduction of the deuterium in the α- and β-position had severe effects on the outcome of product formation ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The decarboxylation reactivity was significantly reduced when the β,β-dideuterated substrate \[3,3-^2^H~2~\]-**2a** was applied, whereas it was slightly promoted with \[2-^2^H\]-**2a**. Similar isotope effects are found for the aromatic \[2-^2^H\]-**4a** (see [Table S28](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf), Supporting Information). This suggests Cβ--H-abstraction as the rate-limiting step for the decarboxylation. On the contrary, desaturation reactivity radically diminished with the α-deuterated \[2-^2^H\]-**2a**, and to a smaller extent, also for \[3,3-^2^H~2~\]-**2a**. Similarly, α-hydroxylation was reduced with the α-deuterated compound, whereas β-deuteration had only marginal effects on this reactivity. This leads to the conclusion that, for desaturation and α-hydroxylation, the rate-limiting hydrogen abstraction takes place at Cα, while Cβ has no impact in the α-hydroxylation and plays only a minor role in desaturation (being the second H that is abstracted). Even though regioselective deuteration is known to potentially alter the reaction center, no switch in regioselectivity toward β-hydroxylation was detectable. Potential additional hydride transfer steps could be ruled out by analysis of MS-fragmentation patterns.^[@ref35]^

###### Product Distributions of the Reaction of ^2^H-Labelled Substrates **2a** with the OleT~JE~/CamAB--FDH System as Mechanistic Probes[a](#t2fn1){ref-type="table-fn"}

![](cs-2018-03733n_0012){#gr4}

Reaction performed on 500 μL scale for 24 h with OleT~JE~/CamAB--FDH system; see the [SI](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf). Conversion is given relative to the conversion obtained with **2a**.

Ratio of formed product of **2a** relative to the deuterated probe (\[2-^2^H\]-**2a** or \[3,3-^2^H~2~\]-**2a**) \[concn(H):concn(D)\].

Computation {#sec3.5}
-----------

To gain insight into the origin of the enantio- and regioselectivity of substrate activation by CYP OleT~JE~ isozymes, a density functional theory study on the mechanisms leading to desaturation, α- and β-hydroxylation and decarboxylation of (*R*)- and (*S*)-2-methylbutyrate (**2a**) by the active iron(IV)-oxo heme cation radical species CYP Compound I (CpdI), was done.^[@ref1],[@ref4],[@ref36]^ This system was studied extensively with computational methods and found to have close-lying doublet and quartet spin states.^[@ref37]^ CpdI was characterized with spectroscopic methods for CYP119, including electron paramagnetic resonance studies and ultraviolet--visible (UV--vis) spectroscopy.^[@ref36]^

Two different active site models of CpdI with substrate (models **A** and **B**) were created, and the substrate activation according to the mechanisms in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} was studied. Focus was set on the large model (model **B**) as it contains the full shape of the substrate binding pocket and hence mimics the real protein better. In general, the absence of the substrate binding pocket residues leads to the lowering of reaction barriers and gives a preference of abstracting the weakest C--H bond. Details of the small model calculations are given in the [SI](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf). The reactions start from a reactant complex (**RC**) of CpdI with the substrate via an initial hydrogen atom abstraction from either Cα--H or Cβ--H via transition states **TS**~HA,α~ and **TS**~HA,β~, respectively. Both systems relax to a radical intermediate consisting of an iron(IV)hydroxo-heme and a nearby radical (**IR1**~α~ and **IR1**~β~; IR, intermediate representation). Past these radical intermediates the mechanisms bifurcate, and from **IR1**~α~ the possibilities are α-oxygen-rebound via **TS**~hydrox,α~ to form α-hydroxylated product (**Pr**~hydrox,α~) or alternatively hydrogen atom abstraction from Cβ via transition state **TS**~desat,α~ to give desaturation products (**Pr**~desat~). The mechanisms from **IR1**~β~ lead to three possible products, namely, desaturation products (**Pr**~desat~) via a second hydrogen atom abstraction via transition state **TS**~desat,β~, radical rebound to form β-hydroxylated products (**Pr**~hydrox,β~) via transition state **TS**~hydrox,β~, and finally decarboxylation via **TS**~decarb,β~ to give olefin, CO~2~, and an iron(III)-hydroxy-heme product (**Pr**~decarb~).

![Reaction mechanisms of (*S*)-2-methylbutyrate (**2a**) activation by a CYP CpdI model with definitions of the nomenclature. Protein residues of model **B** not shown.](cs-2018-03733n_0002){#fig2}

The substrate enantiomers, i.e., (*R*)- and (*S*)-2-methylbutyrate \[(*R*)-**2a** and (*S*)-**2a**\], were docked into the crystal structure coordinates, and several low-energy conformations were found ([Figures S5 and S6](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf), see the SI for details). The geometries of the **RC** were optimized with DFT methods in the doublet and quartet spin states for three substrate (*R*)-conformers (R1, R4, and R7) and five (*S*)-conformers (S1, S2, S3, S5, and S6).

Subsequently, the hydrogen atom abstraction from the Cα--H and Cβ--H positions of the substrate was calculated for all eight **RC** configurations including (*R*)- and (*S*)-enantiomers in the doublet and quartet spin states. Although a possible total of 32 transition states were searched, a large number of those were high in energy and inaccessible due to the position of the substrate in the binding pocket. Particularly, the salt bridge between the substrates' carboxylate and Arg~245~ residue gives considerable restraints to substrate rotation and makes some C--H groups inaccessible for the oxidant. [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} gives the full set of hydrogen atom abstraction transition states located for all substrate binding positions of the (*R*)-enantiomer of 2-methylbutyrate (**2a**). For substrate binding in position R1, only β-hydrogen atom abstraction is found with activation energies of Δ*E* + ZPE^^⧧^^ = 17.6 (quartet) and 18.0 (doublet) kcal mol^--1^. On the other hand, binding orientation R4 only gives accessible Cα--H hydrogen atom abstraction with barriers of 13.9 (quartet) and 14.5 (doublet) kcal mol^--1^. Thus, even though the R4 reactant complexes are higher in energy by 2 kcal mol^--1^, their hydrogen atom abstraction barriers are lower. Structurally, hydrogen atom abstraction transition states ^4,2^**TS**~HA,α,R4~ and ^4,2^**TS**~HA,β,R1~ are alike with short C--H and long O--H distances in the low-spin and the hydrogen atom almost midway in between the donor and acceptor atoms in the high-spin. After the transition states, the complexes relax to a radical intermediate with configuration \[Fe^IV^(OH)(heme)SH\]--Sub^•^ through electron transfer from the substrate into the heme a~2u~ orbital for both doublet and quartet spin states. Reaching the radical intermediates (^4,2^**IR1**~α,R4~ and ^4,2^**IR1**~β,R1~) is an almost thermoneutral process with values of −6.6/--6.6 and 1.2/1.1 kcal mol^--1^, respectively.

![Optimized transition states (^4,2^**TS**~HA,α,R4~ and ^4,2^**TS**~HA,β,R1~) for hydrogen atom abstraction of (*R*)-2-methylbutyrate (**2a**) by CYP OleT~JE~ as calculated in Gaussian with doublet spin data in parentheses. Bond lengths are given in Å and angles in degrees. Energies of activation (in kcal mol^--1^ relative to ^4^**RC**~R1~) calculated at UB3LYP-GD3/BS3//UB3LYP-GD3/BS4 with solvent corrections included. Inaccessible (high-energy) pathways are identified with dashes (−).](cs-2018-03733n_0003){#fig3}

The substrate binding orientation R7 is weaker than R1 and R4 as only one oxygen atom of the carboxylate is involved in the salt bridge with Arg~245~. However, this gives the substrate more flexibility, and now both pathways for Cα--H and Cβ--H hydrogen atom abstraction are accessible. All hydrogen atom abstraction transition states in the R7 conformation are high in energy, and the lowest one (^2^**TS**~HA,α,R7~) has an activation energy of 19.6 kcal mol^--1^. The hydrogen atom abstraction barriers in R7 stay high in energy compared to those found for R1.

All hydrogen atom abstraction pathways for the (*S*)-enantiomer \[(*S*)-**2a**\] of the substrate ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}) were calculated. Although five substrate binding positions were identified, in only three of those viable hydrogen atom abstraction barriers were found. The lowest-energy hydrogen atom abstraction for (*S*)-**2a** by OleT~JE~ CpdI is from the β-position in conformation S1 in the doublet spin state (^2^**TS**~HA,β,S1~) that gives an activation energy of only 10.3 kcal mol^--1^. This barrier is 3.6 kcal mol^--1^ lower in energy than the lowest hydrogen atom abstraction barrier for the (*R*)-enantiomer and would imply faster conversion of (*S*)-**2a** as compared to (*R*)-**2a** by OleT~JE~, which is experimentally confirmed.

![Optimized transition states (^4,2^**TS**~HA,α,S1~, ^4,2^**TS**~HA,β,S1~, ^4,2^**TS**~HA,β,S2~, and ^4,2^**TS**~HA,α,S5~) for hydrogen atom abstraction in (*S*)-2-methylbutyrate by CYP OleT~JE~ as calculated in Gaussian with doublet spin data in parentheses. Bond lengths are given in Å and angles in degrees. Energies of activation (in kcal mol^--1^ relative to ^4^**RC**~R1~) calculated at UB3LYP-GD3/BS3//UB3LYP-GD3/BS4 with solvent corrections included. Inaccessible (high-energy) pathways are identified with dashes (−).](cs-2018-03733n_0004){#fig4}

Within 4 kcal mol^--1^ of ^2^**TS**~HA,β,S1~ there are four more hydrogen atom abstraction barriers, namely, ^4^**TS**~HA,β,S2~ (Δ*E* + ZPE^^⧧^^ = 11.9 kcal mol^--1^), ^2^**TS**~HA,α,S1~ (Δ*E* + ZPE^^⧧^^ = 13.8 kcal mol^--1^), ^2^**TS**~HA,β,S2~ (Δ*E* + ZPE^^⧧^^ = 13.9 kcal mol^--1^), and ^4^**TS**~HA,β,S1~ (Δ*E* + ZPE^^⧧^^ = 14.3 kcal mol^--1^). Another three transition states are within 6 kcal mol^--1^ of ^4^**TS**~HA,β,S2~, see [Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}.

In summary, (*R*)-2-methylbutyrate \[(*R*)-**2a**\] was found to bind preferentially in position R1, but the lowest-energy HAT pathway is for Cα--H abstraction in position R4; as such products resulting from Cα--H abstraction should be dominant. The (*S*)-isomer, by contrast, has close-lying S1 and S2 substrate binding positions that could give Cα--H and Cβ--H hydrogen atom abstraction pathways with lower barriers than those seen for the (*R*)-isomer. As such, theory predicts faster reactivity of (*S*)-**2a** over (*R*)-**2a** in agreement with the experimental turnover numbers ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) that give preferential (*S*)-**2a** reactivity over (*R*)-**2a**. The computational work compares well with experiment and highlights the effect of substrate positioning and the shape and size of the substrate binding pocket on the regio- and chemoselectivity as also highlighted by the experimental results shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Technically, Cα--H hydrogen atom abstraction can lead to desaturation and α-hydroxylation products, whereas Cβ--H hydrogen atom abstraction can give β-hydroxylation, desaturation, and decarboxylation products. Although we did not test these pathways for all our isomeric structures and substrate binding positions, as an example we tested all five pathways for one specific isomer, namely, for (*S*)-**2a** bound in the S1 conformation as this structure gives accessible Cα--H and Cβ--H hydrogen atom abstraction pathways.

For the substrate bound in the S1-position, the full reaction mechanism leading to products was located. Thus, after hydrogen atom abstraction the complexes relax to an intermediate with a radical on Cα (with energies relative to ^4,2^**RC**~S1~ of −7.4 and −7.5 kcal mol^--1^ in the quartet and doublet spin state) or on Cβ (Δ*E* + ZPE = −0.9 and −1.1 kcal mol^--1^ in the quartet and doublet spin state). These relative energies correspond to the relative stability of a tertiary versus secondary carbon radical and favor hydrogen atom abstraction from Cα--H. The size and shape of the substrate binding pocket and oxidant and the rigidity of substrate binding thanks to the Arg~245~ salt bridge means that Cα--H reactivity is not necessarily the most dominant pathway as seen from the relative energies of the transition states in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}. Subsequent reaction of the Cα-radical intermediate (^4,2^**IR**~α,S1~) leads to desaturation with a barrier of 2.8 (0.5) kcal mol^--1^ in the quartet (doublet) spin states, whereas the OH-rebound has a barrier of 3.2 kcal mol^--1^ (quartet spin state). By contrast, after the initial β-hydrogen atom abstraction, we calculated pathways for desaturation (2.8 kcal mol^--1^ on the quartet spin state), β-hydroxylation (3.0 kcal mol^--1^ on the doublet spin state), and decarboxylation (20.1 kcal mol^--1^ on the quartet spin state). Therefore, decarboxylation will be an inaccessible process here, and after β-hydrogen atom abstraction the only products expected will be for desaturation and β-hydroxylation. Previously, QM/MM calculations for arachidonic acid (C~20~) activation by CYP OleT~JE~ gave decarboxylation barriers of \<0.5 kcal mol^--1^ on the doublet spin state and 6.7--8.4 kcal mol^--1^ on the quartet spin state.^[@ref14]^ Although the previous study uses different computational methods and techniques, the overall trends show that replacing arachidonic acid by methylbutyrate (**2a**) raises the decarboxylation barriers significantly as a lesser stable product is formed. This is in agreement with the data shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, where for a long-chain fatty acid, as substrate **1a**, decarboxylation is the dominant product, whereas for **2a** desaturation is observed.

The calculations for the full mechanism for the conversion of reactants bound in conformation S1 to products predict dominant desaturation pathways for (*S*)-**2a** by CYP OleT~JE~ via either ^4,2^**IR**~α,S1~ or ^4,2^**IR**~β,S1~ pathways. In addition, the reaction channel that passes the ^4,2^**IR**~α,S1~ intermediate also gives α-hydroxylation products, whereas β-hydroxylation is accessible for ^2^**IR**~β,S1~. Therefore, the computational studies are in excellent agreement with the product distributions reported above in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}.

Rationalization of the Product Distributions {#sec3.6}
--------------------------------------------

As shown in this work, product-types and distributions of the reaction of CYP OleT~JE~ with substrates are highly dependent on the type of substrate chosen: Linear fatty acids, such as myristic acid (**1a**), are converted by CYP OleT~JE~ to terminal olefins and β-hydroxylation products. By contrast, 2-phenylbutyric acid (**3a**) also gives decarboxylation to form a terminal olefin, but as side product α-hydroxylation (rather than β-hydroxylation) is seen. Finally, 2-methylbutyric acid (**2a**) reacts via desaturation (rather than decarboxylation) alongside α-hydroxylation pathways. The diverse substrate activation by CYP OleT~JE~ is rationalized as follows.

As shown in the past, the reaction rate for hydrogen atom abstraction reactions often correlates with the bond dissociation energy (BDE) of the C--H bond that is broken during the reaction.^[@cit4c],[@ref29],[@ref38]^ Thus, for a hydrogen atom transfer (HAT) reaction between CpdI or \[Fe^IV^(O)(heme^+•^)Cys\], and a substrate (Sub--H), the general equation for HAT as shown in [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} can be formulated. The driving force for that reaction is dependent on the difference in energy of the BDE~CH~ of the substrate and the BDE~OH~ of the iron(IV)-hydroxo complex, [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}.^[@ref39]^

The bond dissociation energies of the Cα--H and Cβ--H bonds of 2-methylbutyric acid (**2a**) are defined as BDE~Cα--H~ and BDE~Cβ--H~. Their values were calculated at UB3LYP/6-31G\* level of theory with dispersion, solvent, and zero-point corrections and give BDE~Cα--H~ = 83.5 and BDE~Cβ--H~ = 94.1 kcal mol^--1^, respectively. Therefore, α-HAT should be significantly preferred over β-HAT in a reaction of CYP Compound I with **2a** under ideal circumstances, i.e., without substrate perturbations by the protein pocket. Together with the BDE~OH~ of the iron(IV)-hydroxo complex of 90.8 kcal mol^--1^ α-HAT and β-HAT are (based on [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}) Δ*E* = −7.3 and +3.3 kcal mol^--1^. These values match the energies to reach the radical intermediates excellently, e.g., compare with Supporting Information, [Table S15](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf).

[Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"} gives the orbital and electron distributions during the hydrogen atom abstraction step. Thus, CpdI has a biradical along the Fe--O bond due to orbital occupation of the antibonding π\*~*xz*~ and π\*~*yz*~ orbitals with one electron. In addition, there is a heme radical (in a~2u~) to give a ferromagnetic quartet or antiferromagnetic doublet spin state.^[@cit4b],[@ref37],[@ref40]^ Upon hydrogen atom abstraction from either Cα--H or Cβ--H these bonds break, and a radical remains on the substrate rest-group designated ϕ~Rα~ and ϕ~Rβ~. The hydrogen atom forms a bond with the oxo group (σ~OH~), and as a result, the π~*xz*~/π\*~*xz*~ pair of orbitals breaks and moves one electron into a~2u~.

![VB depiction of hydrogen atom abstraction from the α- or β-position of 2-methylbutyric acid (**2a**) with orbital changes highlighted and HAT driving forces in kcal mol^--1^ (also given for **1a** and **3a**). Dots represent valence electrons, and a line in between two dots represents a bonding orbital occupied by two electrons.](cs-2018-03733n_0005){#fig5}

To understand the relative barriers, valence bond (VB) modeling was used to predict the hydrogen atom abstraction barriers from empirical relationships as described and explained previously.^[@ref41]^ In particular, a model was devised, based on the vertical energy (*G*~exc~) difference between the reactant and product configuration in the geometry of the reactants plus a component for the driving force (Δ*E*~rp~) from reactants to products as described by [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"} and were derived previously.^[@cit41c]^ Previously, these electronic structure analyses were used to rationalize regioselectivities and substrate activation trends by various iron(IV)-oxo intermediates. To explore whether here also electronic factors contribute to rebound versus desaturation versus decarboxylation processes, we used these VB models to explore the regioselectivities. The reorganization energy *B* is included for the change in structure during the reaction coordinate and is taken as half the value of the weakest of the bonds that are either broken or formed.

For the hydrogen atom transfer, the driving force is simply the difference in energy between the BDE~CH~ and BDE~OH~ as described by [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"} above. The value of *G*~exc~ contains contributions for bond breaking and electron transfer processes that happen in the reaction step. Thus, as shown by the VB structures in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"} during the hydrogen atom abstraction step, one C--H bond from the substrate is broken (BDE~Cα--H~ or BDE~Cβ--H~), but on top of that also the π~*xz*~/π\*~*xz*~ three-electron bond reverts to atomic orbitals. The contribution from this was estimated previously as 136.0 kcal mol^--1^.^[@ref42]^ As such [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"} predicts a hydrogen atom abstraction barrier from the Cα--H and Cβ--H positions of **2a** of 7.6 and 14.6 kcal mol^--1^ ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). These values are in good quantitative agreement with the small model complex calculations. However, the addition of the substrate binding pocket ([Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) raises these values significantly and particularly makes these two pathways competitive. These barriers were also predicted for myristic acid (**1a**) and 2-phenylbutyric acid (**3a**).

In all three substrates, the hydrogen atom abstraction barrier from Cβ--H is similar ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}), but dramatically different on Cα. The BDE~Cα--H~ of **3a** is very small (79.3 kcal mol^--1^) and consequently well-separated from that of Cβ--H. The VB modeling, therefore, predicts dominant products originating from Cα--H hydrogen atom abstraction for substrate **3a**, which is observed experimentally ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). For substrate **1a** the smallest hydrogen atom abstraction difference between Cα--H and Cβ--H is found from VB modeling. Indeed, this substrate gives mostly reaction products originating from Cβ--H abstraction by CpdI ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

Subsequently, the pathways from the radical intermediates (^4,2^**IR1**~α~ and ^4,2^**IR1**~β~) were analyzed, leading to α- and β-hydroxylation, desaturation, and decarboxylation, which are described through the VB analysis in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}.

![VB mechanism for reaction pathways leading to desaturation, hydroxylation, and decarboxylation from radical intermediates during the reaction of CpdI with **2a**.](cs-2018-03733n_0006){#fig6}

From the intermediates ^4,2^**IR1**~α~ the OH-rebound pathway gives 2-hydroxy-2-methylbutyric acid (**2c**) by forming a σ~CO~ bond between the radical and OH groups. At the same time the π~*yz*~/π\*~*yz*~ three-electron bond reverts to atomic orbitals, whereby one electron moves into the σ~CO~ orbital, and the other two remain on iron. A similar mechanism is found for the desaturation pathway from ^4,2^**IR1**~β~. Therefore, the desaturation energy (*E*~desat,α~) from ^4,2^**IR1**~α~ contains contributions for the breaking of the σ~CH~ orbital of Cβ---H (BDE~rad,β~), the energy to break the π~*yz*~/π\*~*yz*~ orbitals (*E*~π/π\*yz~), and the forming of the π-bond of the olefin (*E*~πR~). These contributions were estimated from small model complexes, and a desaturation barrier from ^4,2^**IR**~α~ of 1.6 kcal mol^--1^ was predicted, whereas it is 3.1 kcal mol^--1^ from ^4,2^**IR**~β~. These values are in good agreement with the DFT results presented above. For the radical rebound process, the iron(IV)-hydroxo changes to an iron(III)(heme) weakly coordinating to an alcohol or water molecule. This means that again the π~*yz*~/π\*~*yz*~ orbitals break along the Fe---O bond. On top of that, the radical undergoes major structural changes as the radical center changes from sp^2^ to sp^3^ hybridization upon OH-rebound, and the radical loses its conjugation with the C=O π-bond. An estimation of this conjugation loss to about 70 kcal mol^--1^ raises the VB predicted rebound barriers above the desaturation barriers in energy.

In summary, the product ratios of desaturation versus α- and β-hydroxylation are dependent on the strength of the σ~CO~ orbital formed after rebound versus the difference of the strength of the π-bond in the olefin formed and the loss of conjugation energy of the radical with the carboxylate π-bond. These energy contributions are dependent on the nature of the substrate, and hence different products are obtained for substrates **1a**, **2a**, and **3a**.

Conclusion {#sec4}
==========

Overall, this work provides a detailed insight into the stereoselectivity and reactivity patterns of CYP OleT~JE~ and the CYP152 family in general. The enzymes' biotechnological importance arises from their ability to use H~2~O~2~ as an oxidant and to convert fatty acids into valuable products via oxidative decarboxylation and α- or β-hydroxylation. In this work, we show a novel reaction pathway leading to α,β-desaturation of carboxylic acids. All reactivities were investigated with selectively deuterated substrate probes, revealing the rate-limiting steps. Linear fatty acids generally react with CYP OleT~JE~ by hydrogen atom abstraction from the β-position leading to decarboxylation products. The α,β-desaturase activity reported here is initiated by hydrogen atom abstraction from Cα--H, which is supported by the observation that the desaturation activity often is accompanied by α-hydroxylation. The latter is preferred with substrates bearing an activated Cα and is supported by the strong isotope effect on the desaturation activity.

The product distributions were rationalized with computational studies which revealed that the reactivity highly depends on substrate positioning and involves the carbon with the lowest hydrogen abstraction barrier. Therefore, a weaker Cα--H bond initiates α-hydroxylation and desaturation, and a weaker Cβ--H bond leads to β-hydroxylation and oxidative decarboxylation.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acscatal.8b03733](http://pubs.acs.org/doi/abs/10.1021/acscatal.8b03733).Protein production and purification procedures, chiral and achiral GC- and HPLC-analytics and chromatograms, MS fragmentation patterns, synthetic procedures for substrates and reference compounds including NMR spectra, preparation and characterization of regioselectively deuterated mechanistic probes, control reactions for the verification of enzymatic desaturation, computational methods and data in absolute and relative energies, group spin densities, and charges, and Cartesian coordinates of optimized geometries ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acscatal.8b03733/suppl_file/cs8b03733_si_001.pdf))
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